Publications & Presentations

Publications

• Rising Incidence of Rectal Carcinoma in the Young Age“Is it A Concern? An Indian Perspective

  Authors: Swarupa Mitra*, Parveen Ahlawat, Manoj Sharma, Inderjeet Kaur Wahi, Ruparna Khurana, Shweta Sharma, Raman Narang, Soumya Dutta, Avik Manadal.

  Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India.

  *Corresponding author: Dr. Swarupa Mitra, Senior Consultant, Chief-Gastrointestinal and Genitourinary Radiation Oncology, Rajiv Gandhi Cancer Institute and research Centre, Sector 5, Rohini, Delhi 110085, India.

  Journal: Journal of Cancer Prevention & Current Research | Volume 8 | Issue 4 | 2017

• Treatment of elderly breast cancer patients in a breast center in India

  Authors: Asha Reddy, Naga Amulya Mullapudi, Kirti Katherine Kabeer, Ramesh Nimmagadda¹, Selvi Radhakrishna.

  Chennai Breast Centre, MRC Nagar, Raja Annamalai Puram, ¹Ramesh Nimmagadda Cancer Foundation, Kamaraj Avenue 1st Street, Kasturibai Nagar, Adyar, Chennai, Tamil Nadu, India

  Correspondence : Selvi Radhakrishna

  Journal: Indian Journal of Cancer | Volume 56 | Issue 1 | January-March 2019

• Outcomes of Breast Cancer Management from an Urban Specialist Breast Centre in South India

  Authors: Naga Amulya Mullapudi, Kabeer Katherine Kirti, Naveen Padmanaban¹, Ramesh Nimmagadda², Selvi Radhakrishna

  Department of Oncoplastic Breast Surgery, Chennai Breast Centre, ²Department of Medical Oncology, Apollo Speciality Hospital, Chennai, Tamil Nadu, ¹Department of Surgical Oncology, AIIMS, New Delhi, India

  Correspondence : Selvi Radhakrishna

  Journal: Indian Journal of Medical and Paediatric Oncology | Volume 40 | Issue 5 (Supplement) S102-8 | July 2019

• A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery

  Authors: Dinesh Chandra Doval ^1*, Selvi Radhakrishna², Rupal Tripathi³, Renu Iyer Kashinath⁴,Vineet Talwar¹, Ullas Batra¹, Naga Amulya Mullapudi², Kapil Kumar⁵, Ajay Kumar Dewan⁶,Harit Chaturvedi⁷, Juhi Tayal⁸, Anurag Mehta⁹, Sudeep Gupta¹⁰ & Ramesh B. V. Nimmagadda^4*

  ¹Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India. ²Department of Surgical Oncology, Chennai Breast Centre, Chennai, Tamil Nadu, India. ³Department of Research, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India. ⁴Department of Medical Oncology, Apollo Cancer Institutes, Chennai, Tamil Nadu, India. ⁵Department of Surgical Oncology, Fortis Hospital, Delhi, India. ⁶Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India. ⁷Department of Surgical Oncology, Max Hospital, Delhi, India. ⁸Department of Research (Biorepository), Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India. ⁹Department of Laboratory and Transfusion Services, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India. ¹⁰Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

  Correspondence : Dr Dinesh Chandra Doval, Dr Ramesh B. V. Nimmagadda

  Journal: Scientific Reports | Article No. (2020) 10:5886 | April 2020

• Clinical Outcomes And Patterns Of Failure After D2 Gastrectomy And Adjuvant Chemoradiotherapy In Patients With Locally Advanced Carcinoma Stomach: A Retrospective Review From A Tertiary Care Cancer Research Institute

  Authors: Swarupa Mitra, Ruparna Khurana, Abhinav Dewan, Inderjeet Kaur Wahi, Sumeet Aggarwal, Soumitra Barik, Soumya Dutta, Varghese Antony, Manindra Mishra

  Rajiv Gandhi Cancer Institute and Research Centre. New Delhi. India

  Poster at ASTRO Meeting, Chicago, September 2019

• Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry

  Authors: Reena Nair^1*, Dinesh Bhurani², Senthil Rajappa³, Asha Kapadia⁴, Rakesh Reddy Boya⁵, Subramanian Sundaram⁶, Hari Menon⁷, Ganapathi S. Raman⁸, Arun Seshachalam⁹ and Ramesh Nimmagadda¹⁰

  ₁Department of Clinical Hematology, Tata Medical Center, Kolkata, India, ₂Department of Haematology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India, ₃Department of Medical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India, ₄Department of Medical Oncology, PD Hinduja National Hospital and Medical Research Center, Mumbai, India, ₅Department of Medical Oncology, Mahatma Gandhi Cancer Hospital and Research Institute, Visakhapatnam, India, ₆Department of Medical Oncology, V S Hospitals, Chennai, India, ₇Department of Medical Oncology, CyteCare Cancer Hospitals, Bengaluru, India, ₈Department of Medical Oncology, Kumaran Hospital (P) Ltd. (MCCF), Chennai, India, ₉Department of Medical Oncology, Dr GVN Cancer Institute, Trichy, India, ₁₀Department of Medical Oncology, Apollo Cancer Institute, Chennai, India

  Correspondence : Reena Nair; orcid.org/0000-0003-3032-1350

  Frontiers in Oncology. 11:796962 | 02 February 2022 | doi: 10.3389/fonc.2021.796962

• Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India

  Authors: Dinesh Bhurani^1*, Reena Nair² , Senthil Rajappa³, Suparna Ajit Rao⁴, Nithya Sridharan⁵, Rakesh Reddy Boya⁶, Ganapathi S. Raman⁷, Hari Menon⁸, Arun Seshachalam⁹ and Ramesh Nimmagadda¹⁰

  ₁Department of Haematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India, ₂Department of Haematology, Tata Medical Centre, Kolkata, India, ₃Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India, ₄Department of Medical Oncology, P. D. Hinduja Hospital and Medical Research Centre, Mumbai, India, ₅Department of Medical Oncology, VS Hospitals, Chennai, India, ₆Department of Medical Oncology, Mahatama Gandhi Cancer Hospital and Research Center, Visakhapatnam, India, ₇Department of Medical Oncology, Kumaran Hospital Private Ltd., Chennai, India, ₈Department of Medical Oncology, CyteCare Cancer Hospitals, Bengaluru, India, ₉Department of Medical Oncology, GVN Hospital, Trichy, India, ₁₀Department of Medical Oncology, Apollo Cancer Institute, Chennai, India

  Correspondence : Dinesh Bhurani

  Frontiers in Oncology. 11:799948 | 11 February 2022 | doi: 10.3389/fonc.2021.799948

Presentations